Inside Next-Gen Platforms For Cell Therapy Manufacturing

With additional cell therapy approvals on the horizon, a diverse array of products and platforms are needed to help ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall CoGS. Streamlined manufacturing is the goal, but challenges persist. Innovations in closed systems, automation, standardization, and more are needed to bring cell therapies to patients as soon as possible.